Abstract
MicroRNAs (miRNAs) play important role in regulating cellular metabolism, and are currently being explored in cancer. As metabolic reprogramming in cancer is a major mediator of phenotypic plasticity, understanding miRNA-regulated metabolism will provide opportunities to identify miRNA targets that can regulate oncogenic phenotypes by taking control of cellular metabolism. In the present work, we studied the effect of differentially expressed miRNAs on metabolism, and associated oncogenic phenotypes in glioblastoma (GBM) using patient-derived data. Networks of differentially expressed miRNAs and metabolic genes were created and analyzed to identify important miRNAs that regulate major metabolism in GBM. Graph network-based approaches like network diffusion, backbone extraction, and different centrality measures were used to analyze these networks for identification of potential miRNA targets. Important metabolic processes and cellular phenotypes were annotated to trace the functional responses associated with these miRNA-regulated metabolic genes and associated phenotype networks. miRNA-regulated metabolic gene subnetworks of cellular phenotypes were extracted, and important miRNAs regulating these phenotypes were identified. The most important outcome of the study is the target miRNA combinations predicted for five different oncogenic phenotypes that can be tested experimentally for miRNA-based therapeutic design in GBM. Strategies implemented in the study can be used to generate testable hypotheses in other cancer types as well, and design context-specific miRNA-based therapy for individual patient. Their usability can be further extended to other gene regulatory networks in cancer and other genetic diseases.
Similar content being viewed by others
References
Alfardus H, de los Angeles Estevez-Cebrero M, Rowlinson J et al (2021) Intratumour heterogeneity in microRNAs expression regulates glioblastoma metabolism. Sci Rep 11:15908
Aloizou A-M, Pateraki G, Siokas V, Mentis A-FA, Liampas I, Lazopoulos G, Kovatsi L, Mitsias PD, Bogdanos DP, Paterakis K et al (2020) The role of MiRNA-21 in gliomas: hope for a novel therapeutic intervention? Toxicol Rep 7:1514–1530
Banelli B, Forlani A, Allemanni G, Morabito A, Pistillo MP, Romani M (2017) MicroRNA in glioblastoma: an overview. Int J Genomics 2017:7639084
Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M (2012) NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res 41:D991–D995
Bastian M, Heymann S, and Jacomy M (2009) Gephi: an open source software for exploring and manipulating networks. In: Proceedings of the international AAAI conference on web and social media, vol 3. AAAI ICWSM’09, San Jose, California, pp 361–362
Bendahou MA, Ibrahimi A, Boutarbouch M (2020) Bioinformatics analysis of differentially expressed genes and mirnas in low-grade gliomas. Cancer Inform 19:1176935120969692
Bhowmick R, Subramanian A, Sarkar RR (2015) Exploring the differences in metabolic behavior of astrocyte and glioblastoma: a flux balance analysis approach. Syst Synth Biol 9:159–177
Bradley BS, Loftus JC, Mielke CJ, Dinu V (2014) Differential expression of microRNAs as predictors of glioblastoma phenotypes. BMC Bioinform 15:21
Buruiană A, Florian I, Florian AI et al (2020) The roles of miRNA in glioblastoma tumor cell communication: diplomatic and aggressive negotiations. Int J Mol Sci 21:1950
Cai S, Shi CJ, Lu JX, Wang YP, Yuan T, Wang XP (2021) miR-124-3p inhibits the viability and motility of glioblastoma multiforme by targeting RhoG. Int J Mol Med 47:1–3
Carlin DE, Demchak B, Pratt D, Sage E, Ideker T (2017) Network propagation in the cytoscape cyberinfrastructure. PLoS Comput Biol 13:e1005598
Chen X, Dong D, Pan C, Xu C, Sun Y, Geng Y, Kong L, Xiao X, Zhao Z, Zhou W et al (2018) Identification of grade-associated MicroRNAs in brainstem gliomas based on microarray data. J Cancer 9:4463–4476
Chen Y, Wang X (2019) miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res 48:D127–D131
Chen M, Medarova Z, Moore A (2021) Role of microRNAs in glioblastoma. Oncotarget 12:1707–1723
Cheng CP, Huang LC, Chang YL, Hsieh CH, Huang SM, Hueng DY (2016) The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas. Oncotarget 7:41460–41472
Csardi G, Nepusz T (2006) The igraph software package for complex network research. Int J Complex Syst 1695:1–9
Saldanha Gama Fischer J, Costa Carvalho P, da Fonseca CO et al (2011) Chemo-resistant protein expression pattern of glioblastoma cells (A172) to perillyl alcohol. J Proteome Res 10:153–160
Domagalski R, Neal ZP, Sagan B (2021) Backbone: An R package for extracting the backbone of bipartite projections. PLoS ONE 16:e0244363
Feng L, Ma J, Ji H, Liu Y, Hu W (2017) miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5. Biosci Rep. https://doi.org/10.1042/BSR20170019
Gabriely G, Yi M, Narayan RS, Niers JM, Wurdinger T, Imitola J, Ligon KL, Kesari S, Esau C, Stephens RM et al (2011) Human glioma growth is controlled by microRNA-10b. Cancer Res 71:3563–3572
Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT et al (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458:762–765
Gao ZG, Yang P, Huang J, Ding YQ (2021) CircFBXW7 alleviates glioma progression through regulating miR-23a-3p/PTEN axis. Anat Rec (hoboken) 304:279–290
García-Moreno A, López-Domínguez R, Ramirez-Mena A, Pascual-Montano A, Aparicio-Puerta E, Hackenberg M, Carmona-Saez P (2021) GeneCodis 4: expanding the modular enrichment analysis to regulatory elements. bioRxiv. https://doi.org/10.1101/2021.04.15.439962
Gillespie M, Jassal B, Stephan R, Milacic M, Rothfels K, Senff-Ribeiro A, Griss J, Sevilla C, Matthews L, Gong C et al (2021) The reactome pathway knowledgebase 2022. Nucleic Acids Res 50:D687–D692
Gulluoglu S, Tuysuz EC, Sahin M, Kuskucu A, KaanYaltirik C, Ture U, Kucukkaraduman B, Akbar MW, Gure AO, Bayrak OF et al (2018) Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes. Brain Res 1700:199–210
Gustavsen JA, Pai S, Isserlin R, Demchak B, Pico AR (2019) RCy3: Network biology using cytoscape from within R. F1000Res 8:1774
Hermansen SK, Sørensen MD, Hansen A, Knudsen S, Alvarado AG, Lathia JD, Kristensen BW (2017) A 4-miRNA signature to predict survival in glioblastomas. PLoS ONE 12:e0188090
Hintze A, Adami C (2010) Modularity and anti-modularity in networks with arbitrary degree distribution. Biol Direct 5:32
Huo L, Wang B, Zheng M, Zhang Y, Xu J, Yang G, Guan Q (2019) miR-128-3p inhibits glioma cell proliferation and differentiation by targeting NPTX1 through IRS-1/PI3K/AKT signaling pathway. Exp Ther Med 17:2921–2930
Ivo D’Urso P, Fernando D’Urso O, Damiano Gianfreda C, Mezzolla V, Storelli C, Marsigliante S (2015) miR-15b and miR-21 as circulating biomarkers for diagnosis of glioma. Curr Genomics 16:304–311
Jalili M, Salehzadeh-Yazdi A, Asgari Y, Arab SS, Yaghmaie M, Ghavamzadeh A, Alimoghaddam K (2015) CentiServer: a comprehensive resource, web-based application and r package for centrality analysis. PLoS ONE 10:e0143111
Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, Sidiropoulos K, Cook J, Gillespie M, Haw R et al (2020) The reactome pathway knowledgebase. Nucleic Acids Res 48:D498-d503
Jia X, Wang X, Guo X, Ji J, Lou G, Zhao J, Zhou W, Guo M, Zhang M, Li C et al (2019) MicroRNA-124: an emerging therapeutic target in cancer. Cancer Med 8:5638–5650
Kanehisa M, Sato Y (2020) KEGG Mapper for inferring cellular functions from protein sequences. Protein Sci 29:28–35
Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M (2021) KEGG: integrating viruses and cellular organisms. Nucleic Acids Res 49:D545-d551
Kant S, Kesarwani P, Prabhu A, Graham SF, Buelow KL, Nakano I, Chinnaiyan P (2020) Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment. Cell Death Dis 11:253
Karsy M, Arslan E, Moy F (2012) Current progress on understanding micrornas in glioblastoma multiforme. Genes Cancer 3:3–15
Katz L (1953) A new status index derived from sociometric analysis. Psychometrika 18:39–43
Khwairakpam AD, Shyamananda MS, Sailo BL, Rathnakaram SR, Padmavathi G, Kotoky J, Kunnumakkara AB (2015) ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment. Curr Drug Targets 16:156–163
Kouhkan F, Mobarra N, Soufi-Zomorrod M, Keramati F, Hosseini Rad SM, Fathi-Roudsari M, Tavakoli R, Hajarizadeh A, Ziaei S, Lahmi R et al (2016) MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1. J Med Genet 53:24–33
Li H, Li Y, Tian D, Zhang J, Duan S (2021) miR-940 is a new biomarker with tumor diagnostic and prognostic value. Mol Ther Nucleic Acids 25:53–66
Linnebank M, Semmler A, Moskau S, Smulders Y, Blom H, Simon M (2008) The methylenetetrahydrofolate reductase (MTHFR) variant c.677C>T (A222V) influences overall survival of patients with glioblastoma multiforme. Neuro Oncol 10:548–552
Liu Z, Su D, Qi X, Ma J (2018) MiR-500a-5p promotes glioblastoma cell proliferation, migration and invasion by targeting chromodomain helicase DNA binding protein 5. Mol Med Rep 18:2689–2696
Lou W, Ding B, Xu L, Fan W (2019) Construction of potential glioblastoma multiforme-related miRNA-mRNA regulatory network. Front Mol Neurosci 12:66
Macfarlane LA, Murphy PR (2010) MicroRNA: biogenesis, function and role in cancer. Curr Genomics 11:537–561
McCarthy DJ, Chen Y, Smyth GK (2012) Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res 40:4288–4297
Medarova Z, Pantazopoulos P, Yoo B (2020) Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells. Sci Rep 10:1970
Menyhárt O, Győrffy B (2021) Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis. Comput Struct Biotechnol J 19:949–960
Pavlopoulos GA, Kontou PI, Pavlopoulou A, Bouyioukos C, Markou E, Bagos PG (2018) Bipartite graphs in systems biology and medicine: a survey of methods and applications. GigaScience 7:1–31
Pedroza-Torres A, Romero-Córdoba SL, Justo-Garrido M, Salido-Guadarrama I, Rodríguez-Bautista R, Montaño S, Muñiz-Mendoza R, Arriaga-Canon C, Fragoso-Ontiveros V, Álvarez-Gómez RM et al (2019) MicroRNAs in tumor cell metabolism: roles and therapeutic opportunities. Front Oncol 9:1404
Piwecka M, Rolle K, Belter A, Barciszewska AM, Żywicki M, Michalak M, Nowak S, Naskręt-Barciszewska MZ, Barciszewski J (2015) Comprehensive analysis of microRNA expression profile in malignant glioma tissues. Mol Oncol 9:1324–1340
Potapov AP, Goemann B, Wingender E (2008) The pairwise disconnectivity index as a new metric for the topological analysis of regulatory networks. BMC Bioinformatics 9:227
Qin CZ, Lv QL, Yang YT, Zhang JM, Zhang XJ, Zhou HH (2017) Downregulation of MicroRNA-320d predicts poor overall survival and promotes the growth and invasive abilities in glioma. Chem Biol Drug Des 89:806–814
Qiu S, Huang D, Yin D, Li F, Li X, Kung HF, Peng Y (2013) Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme. Biochem Biophys Acta 1832:1697–1707
Rasper M, Schäfer A, Piontek G, Teufel J, Brockhoff G, Ringel F, Heindl S, Zimmer C, Schlegel J (2010) Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro Oncol 12:1024–1033
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47–e47
Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discovery 16:203–222
Sana J, Busek P, Fadrus P, Besse A, Radova L, Vecera M, Reguli S, StollinovaSromova L, Hilser M, Lipina R et al (2018) Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival. Sci Rep 8:2836
Sasayama T, Tanaka K, and Kohmura E (2016) The roles of microRNAs in glioblastoma biology and biomarker. In: Agrawal A (ed) Neurooncology, 1st edn. Newer Developments, p 27–66
Saurty-Seerunghen MS, Bellenger L, El-Habr EA, Delaunay V, Garnier D, Chneiweiss H, Antoniewski C, Morvan-Dubois G, Junier MP (2019) Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells. Acta Neuropathol Commun 7:155
Semonche A, Shah AH, Ivan ME, Komotar RJ (2019) Towards a microRNA-based gene therapy for glioblastoma. Neurosurgery 85:E210-e211
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504
Sharkey KJ (2017) A control analysis perspective on Katz centrality. Sci Rep 7:17247
Shea A, Harish V, Afzal Z, Chijioke J, Kedir H, Dusmatova S, Roy A, Ramalinga M, Harris B, Blancato J et al (2016) MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med 5:1917–1946
Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF et al (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6:14
Szczepanek J, Skorupa M, Tretyn A (2022) MicroRNA as a potential therapeutic molecule in cancer. Cells 11:1008
Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P et al (2020) The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res 49:D605–D612
Veillon L, Fakih C, Abou-El-Hassan H, Kobeissy F, Mechref Y (2018) Glycosylation Changes in brain cancer. ACS Chem Neurosci 9:51–72
Wang N, Tan HY, Feng YG, Zhang C, Chen F, Feng Y (2018a) microRNA-23a in human cancer: its roles, mechanisms and therapeutic relevance. Cancers 11:7
Wang R, Zuo X, Wang K, Han Q, Zuo J, Ni H, Liu W, Bao H, Tu Y, Xie P (2018b) MicroRNA-485-5p attenuates cell proliferation in glioma by directly targeting paired box 3. Am J Cancer Res 8:2507–2517
Wang X, Dalkic E, Wu M, Chan C (2008) Gene module level analysis: identification to networks and dynamics. Curr Opin Biotechnol 19:482–491
Wang WY, Lu WC (2020) Reduced expression of hsa-miR-338-3p contributes to the development of glioma cells by targeting mitochondrial 3-Oxoacyl-ACP Synthase (OXSM) in glioblastoma (GBM). Onco Targets Ther 13:9513–9523
Wang Y, Chen R, Zhou X, Guo R, Yin J, Li Y, Ma G (2020) miR-137: a novel therapeutic target for human glioma. Mol Ther Nucleic Acids 21:614–622
Wickham H, Averick M, Bryan J, Chang W, McGowan LDA, François R, Grolemund G, Hayes A, Henry L, Hester J (2019) Welcome to the tidyverse. J Open Source Softw 4:1686
Xiong W, Ran J, Jiang R, Guo P, Shi X, Li H, Lv X, Li J, Chen D (2018) miRNA-320a inhibits glioma cell invasion and migration by directly targeting aquaporin 4. Oncol Rep 39:1939–1947
Xu W, Liu M, Peng X, Zhou P, Zhou J, Xu K, Xu H, Jiang S (2013) miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. Int J Oncol 42:757–766
Yan C, Kong X, Gong S, Liu F, Zhao Y (2020) Recent advances of the regulation roles of MicroRNA in glioblastoma. Int J Clin Oncol 25:1215–1222
Yeh M, Wang YY, Yoo JY, Oh C, Otani Y, Kang JM, Park ES, Kim E, Chung S, Jeon YJ et al (2021) MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44. Sci Rep 11:9219
Yin CY, Kong W, Jiang J, Xu H, Zhao W (2019) miR-7-5p inhibits cell migration and invasion in glioblastoma through targeting SATB1. Oncol Lett 17:1819–1825
Yu J, Wu SW, Wu WP (2017) A tumor-suppressive microRNA, miRNA-485-5p, inhibits glioma cell proliferation and invasion by down-regulating TPD52L2. Am J Transl Res 9:3336–3344
Zhan J, Gurung S, Parsa SPK (2017) Identification of top-K nodes in large networks using Katz centrality. J Big Data 4:16
Zhang JF, Zhang JS, Zhao ZH, Yang PB, Ji SF, Li N, Shi QD, Tan J, Xu X, Xu CB et al (2018) MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma. Cancer Cell Int 18:195
Zhao C, Guo R, Guan F, Ma S, Li M, Wu J, Liu X, Li H, Yang B (2020) MicroRNA-128-3p enhances the chemosensitivity of temozolomide in glioblastoma by targeting c-Met and EMT. Sci Rep 10:9471
Zhu Z, Leung GKK (2020) More than a metabolic enzyme: MTHFD2 as a novel target for anticancer therapy? Front Oncol 10:658
Acknowledgements
RB acknowledges Council of Scientific & Industrial Research (CSIR) for the Senior Research Fellowship (CSIR File No.: 31/011(1047)/2018-EMR-I dated 26-04-2018). RRS acknowledges CSIR-National Chemical Laboratory for funding support (MLP038826) to carry out this work.
Author information
Authors and Affiliations
Contributions
RRS conceived and conceptualized the work. RB designed the methodologies, wrote and executed the computer programs and performed the simulations and analyses. RB wrote the original manuscript. RRS supervised the work, reviewed and edited the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interests.
Additional information
Communicated by Shuhua Xu.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bhowmick, R., Sarkar, R.R. Identification of potential microRNAs regulating metabolic plasticity and cellular phenotypes in glioblastoma. Mol Genet Genomics 298, 161–181 (2023). https://doi.org/10.1007/s00438-022-01966-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00438-022-01966-3